Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
Daiichi Sankyo has postponed its annual report by two weeks to allow for additional time to finalize the financial figures. | Daiichi Sankyo has postponed its annual report by two weeks, citing additional time needed to review “the supply plans for its oncology products portfolio and development pipeline.”
.jpg?VersionId=n0KnS8CukIXu_ZzxDy6WwpiYtPcK3VYS#)
.jpg?VersionId=n0KnS8CukIXu_ZzxDy6WwpiYtPcK3VYS)
Daiichi Sankyo has postponed its annual report by two weeks to allow for additional time to finalize the financial figures. | Daiichi Sankyo has postponed its annual report by two weeks, citing additional time needed to review “the supply plans for its oncology products portfolio and development pipeline.”
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
